NCT06203717

Brief Summary

The goal of this study is to test whether active duty firefighters find it possible and suitable to do cranial electrotherapy stimulation (CES) at home, and test whether CES influences measures of depression and posttraumatic stress. The main questions it aims to answer are:

  • is CES feasible and acceptable in a population of firefighters, and
  • does CES changes feelings of depression, anxiety, and fatigue in firefighters. Participants will
  • complete four weeks of CES at home, and
  • complete daily assessments of affect and fatigue, and
  • complete self-reported symptoms of depression and posttraumatic stress before and after four weeks of CES at home Participants maybe asked to
  • complete an MRI scan before and after four weeks of CES at, and
  • wear a device to measure their heart rate and sleep quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

April 29, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 3, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 3, 2025

Completed
5 months until next milestone

Results Posted

Study results publicly available

November 5, 2025

Completed
Last Updated

November 5, 2025

Status Verified

October 1, 2025

Enrollment Period

1.1 years

First QC Date

November 8, 2023

Results QC Date

October 14, 2025

Last Update Submit

October 14, 2025

Conditions

Keywords

Firefighters

Outcome Measures

Primary Outcomes (2)

  • Feasibility of Cranial Electrotherapy Stimulation

    Feasibility assessed by number of completed cranial electrotherapy stimulation sessions over the course of four weeks (feasible is defined as more than 75% of sessions completed).

    During four weeks of cranial electrotherapy stimulation at-home use

  • Acceptability of Cranial Electrotherapy Stimulation

    Acceptability assessed by number of individuals who complete at least 75% of all cranial electrotherapy stimulation sessions during four weeks

    During four weeks of cranial electrotherapy stimulation

Secondary Outcomes (4)

  • Severity of Symptoms of Posttraumatic Stress Disorder as Measured With the PTSD Checklist for DMS 5 (PCL-5)

    Post four weeks of cranial electrotherapy stimulation

  • Severity of Symptoms of Depression as Measured With the Inventory of Depressive Symptomatology-Self Report (IDS-SR)

    post four weeks of cranial electrotherapy stimulation.

  • Intensity of Feelings of Fatigue

    Daily throughout four weeks of cranial electrotherapy stimulation

  • Intensity of Feelings of Anxiety

    Daily throughout four weeks of cranial electrotherapy stimulation

Study Arms (1)

Alpha-Stim AID cranial electrotherapy stimulation

EXPERIMENTAL

Four-week course of noninvasive cranial electrotherapy stimulation.

Device: Alpha-Stim AID cranial electrotherapy stimulation

Interventions

Cranial electrotherapy stimulation using a modified square, bipolar waveform of 0.5 Hz at 100 μA to be used for four weeks on off-duty days.

Alpha-Stim AID cranial electrotherapy stimulation

Eligibility Criteria

Age18 Years - 56 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Active duty firefighter in Rhode Island, USA;
  • Age between 18 and 56 years old;
  • Be in good medical health or, if having chronic medical conditions, these conditions needed to be stable;
  • Ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent.

You may not qualify if:

  • MRI and CES-related contraindications, e.g., implanted metallic device or substances including pacemakers, cochlear implant, metallic tattoos, claustrophobia, pregnancy or planning to become pregnant during the study duration and nursing;
  • Neurological conditions such as brain neoplasm, cerebrovascular events, epilepsy or history of seizures, dementia, and neurodegenerative disorders, or had previously received brain surgery;
  • Report presence of suicidal ideation on QuickSCID-5 or has attempted suicide one or more times within the past twelve months;
  • Exhibiting a psychiatric condition that would require inpatient or partial psychiatric hospitalization;
  • Current moderate or severe alcohol or other substance abuse (excluding nicotine);
  • Major or unstable medical illness requiring further investigation or treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Butler Hospital

Providence, Rhode Island, 02906, United States

Location

Results Point of Contact

Title
Mascha van 't Wout-Frank
Organization
Butler Hospital

Study Officials

  • Mascha van 't Wout-Frank, PhD

    Butler Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2023

First Posted

January 12, 2024

Study Start

April 29, 2024

Primary Completion

June 3, 2025

Study Completion

June 3, 2025

Last Updated

November 5, 2025

Results First Posted

November 5, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations